ArticleJournal of exercise science and fitness2026
Clustering of non-invasive biomarkers to distinguish phenotype-related response differences in women with PCOS after the 16-week Nordic interval training intervention: A prospective cohort study.
Article in Journal of exercise science and fitness, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic ovary syndrome (PCOS) is associated with metabolic and reproductive abnormalities. Response variability due to exercise may reflect underlying biological heterogeneity in PCOS phenotypes. We explored changes in non-invasive PCOS biomarkers following a 16-week Interval Nordic Walking (INW) to identify phenotype-related response differences. Methods: A total of 7500 women's data were obtained from the Yazd Reproductive Sciences and Amir al Mómenin Hospital (2019-2024). PCOS was diagnosed according to the Rotterdam criteria. XGBoost feature selection was implemented to choose 17 key predictors. Multiple ML classifiers were evaluated, and model interpretability was achieved using SHAP values. 80 women with different PCOS phenotypes completed a 16-week INW intervention. PCA was applied to reduce the features to 75% variance. Then clustering algorithms (K-means, GMM, Hierarchical, Spectral, DBSCAN) were evaluated using Silhouette scores, Calinski-Harabasz indices, and bootstrap resampling (Jaccard index). Results: XGBoost and SHAP analysis confirmed AMH, FSH, and Anti-TPO as the most influential predictors of PCOS, while metabolic indices like HbA1c, BMI, and lipid profiles exhibited moderate but clinically relevant effects. The spectral model provided better separation among evaluated algorithms; however, overall cluster separation remained modest. It suggested two exploratory data-driven response patterns, termed high-response (more frequently observed phenotypes one and two), which demonstrated greater observed reductions in testosterone and DHEA-s along with improvements in HDL and total cholesterol following the intervention. Low-response (more frequently observed phenotypes three and four) showed relatively minimal response to INW. Based on mean Jaccard index = 0.45, cluster stability was moderate. Conclusions: Our study suggests the heterogeneous phenotypic response pattern of PCOS following a 16-week INW intervention and supports further investigation of nonpharmacological strategies for PCOS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.